Ortivus’ Year-end Report, January – December 2020
2021-02-16 08:30
Ortivus – An eHealth company on the front line
Highlights Oct – Dec 2020
- Ortivus signs a contract with Region Jönköping for the delivery of MobiMed monitoring, hardware and software, to all of the regions emergency vehicles. The order value is approximately 9.0 MSEK
- Ortivus communicates that production, reparations and warehouse management of MobiMed Monitoring, will be moved to Ortivus’ own premises in Danderyd and taken over by Ortivus’ own personnel. Mentioned functions are today handled by Inission in Västerås.
- Ortivus signs an exclusive distribution agreement with OsatuS. Coop / Bexencardio. The agreement gives Ortivus the possibility to offer Bexencardios AEDs. The agreement is valid for the Nordic countries, UK and Ireland.
Oct – Dec 2020
- Net sales amounted to 21.9 (17.1) MSEK, which is an increase in sales of 27.8%
- Operating profit cleared for comparative distortion items amounted to 2.2 (-1.7) MSEK. Operating profit, including comparative distortion items, amounted to 2.2 (-1.7) MSEK
- EBITDA cleared for comparative distortion items, amounted to 2.5 (0.2) MSEK. EBITDA including comparative distortion items, amounted to 2.5 (0.2) MSEK
- Profit after tax was 2.2 (-1.7) MSEK
- Earnings per share after tax amounted to 0.05 (-0.04) SEK
Jan – Dec 2020
- Net sales amounted to 107.6 (50.8) MSEK, which is an increase in sales of 111.6%
- Operating profit cleared for comparative distortion items, amounted to 11.4 (-10.2) MSEK. Operating profit including comparative distortion items, amounted to 11.4 (-15.5) MSEK
- EBITDA cleared for comparative distortion items, amounted to 13.9 (-8.5) MSEK. EBITDA including comparative distortion items, amounted to 13.9 (-8.5) MSEK
- Profit after tax was 11.3 (16.0) MSEK
- Earnings per share after tax amounted to 0.26 (-0.41) SEK
| Amount in KSEK | Okt – Dec 2020 | Okt – Dec 2019 | Jan – Dec 2020 | Jan – Dec 2019 |
| Net sales | 21 863 | 17 101 | 107 582 | 50 848 |
| Gross margin, % | 49.0% | 49.6% | 36.2% | 41.3% |
| Operating profit, excl. comparative distortion items |
2 167 | -1 731 | 11 392 | -10 197 |
| Operating margin, % excl. comparative distortion items |
9.9% | -10.1% | 10.6% | -20.1% |
| EBITDA, excl. comparative distortion items |
2 459 | 200 | 13 896 | -3 271 |